Page last updated: 2024-11-03

propranolol and Neuroendocrine Tumors

propranolol has been researched along with Neuroendocrine Tumors in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kaulanjan-Checkmodine, P1
Oucherif, S1
Prey, S1
Gontier, E1
Lacomme, S1
Loot, M1
Miljkovic-Licina, M1
Cario, M1
Léauté-Labrèze, C1
Taieb, A1
Moisan, F1
Rezvani, HR1

Other Studies

1 other study available for propranolol and Neuroendocrine Tumors

ArticleYear
Is Infantile Hemangioma a Neuroendocrine Tumor?
    International journal of molecular sciences, 2022, May-05, Volume: 23, Issue:9

    Topics: Adrenergic beta-Antagonists; Endothelial Cells; Hemangioma; Humans; Infant; Infant, Newborn; Neuroen

2022